As blockbuster GLP-1 injectables like Mounjaro, Wegovy and Ozempic gain traction in India, doctors stress that careful ...
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...
Eli Lilly has quietly turned a blockbuster obesity and diabetes franchise into one of the market's most intriguing income ...
Eli Lilly is a well-established pharmaceutical company with a portfolio of products that consistently generate revenue and ...